Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

37.12
Delayed Data
As of Sep 02
 +1.37 / +3.83%
Today’s Change
6.51
Today|||52-Week Range
39.02
+268.99%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close35.75
Today’s open37.01
Day’s range35.20 - 37.15
Volume1,109,433
Average volume (3 months)1,097,230
Market cap$1.3B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+1.51%
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book17.20

Competitors

 Today’s
change
Today’s
% change
ZSPHZS Pharma Inc+3.47+6.82%
EBSEmergent BioSolution...+0.90+2.75%
PTCTPTC Therapeutics Inc+1.43+3.87%
NLNKNewLink Genetics Cor...+2.94+6.78%
Data as of 09/02/2015

Financials

Next reporting dateNovember 16, 2015
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers